HAEMONETICS CORP (HAE) - Comprehensive Stock Analysis & Investment Research
Deep dive into HAEMONETICS CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Understanding Company Overview
What this section covers: Essential business information about HAEMONETICS CORP, including sector classification, industry positioning, and organizational structure.
How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.
For HAEMONETICS CORP: HAEMONETICS CORP operates in the Industrial Applications and Services sector, establishing it as a mid-cap growth opportunity.
HAEMONETICS CORP (Stock Symbol: HAE) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.
The organization employs approximately 3300 professionals worldwide .
The company has established itself as a growing mid-cap opportunity with strong fundamentals.
Understanding Financial Performance
What these metrics mean: Key financial indicators showing HAEMONETICS CORP's revenue scale, profitability, market value, and shareholder returns.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For HAEMONETICS CORP: With $993M in annual revenue and 4.4% net margin, the company demonstrates developing profitability.
Annual Revenue: $993 million generating a 4.4% net profit margin .
Market Capitalization: $3541 million - Classified as a mid-cap growth stock with balanced risk-reward profile.
Return on Equity (ROE): 5.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.
Understanding AI Stock Predictions
What these predictions mean: AI-powered forecasts for HAEMONETICS CORP stock using machine learning algorithms trained on historical market data and technical indicators.
How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.
For HAEMONETICS CORP: Unlock premium access to view detailed AI predictions and price targets.
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for HAEMONETICS CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Understanding Market Position
What this analysis covers: HAEMONETICS CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.
How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.
For HAEMONETICS CORP: Strong free cash flow generation demonstrates developing operational efficiency.
HAEMONETICS CORP strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .
The company demonstrates robust operational efficiency through strong free cash flow generation of $76 million annually, complemented by impressive -31.2% year-over-year cash flow growth.
The company maintains a healthy 50.9% gross margin, indicating strong pricing power and operational efficiency.